AP

Anjali Pandey

SC Srx Cardio: 5 patents #1 of 8Top 15%
SL Sami-Sabinsa Group Limited: 1 patents #4 of 6Top 70%
📍 Fremont, CA: #47 of 1,881 inventorsTop 3%
🗺 California: #1,572 of 67,048 inventorsTop 3%
Overall (2024): #12,274 of 561,600Top 3%
9
Patents 2024

Issued Patents 2024

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12122785 Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors Gregory Dietsch, Bhaskar Chaudhuri, Seetharaman MANOJVEER, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy +1 more 2024-10-22
12115154 Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) Simeon Bowers, Mark Karbarz, Jiang Zhu, Thomas E. Barta, Jonathan William Bourne 2024-10-15
12103937 Substituted pyridines and pyridazines as TYK2 inhibitors Gregory Dietsch, Seetharaman MANOJVEER, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh KALVA 2024-10-01
12084458 Substituted pyridines, pyridazines, and pyrimidines as TYK2 inhibitors Gregory Dietsch, Seetharaman MANOJVEER, Mahesh Thakkar, Athisayamani Jeyaraj Duraiswamy, Sukesh KALVA 2024-09-10
11945782 Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers 2024-04-02
11944619 Phenylalanine small organic compounds to directly modulate PCSK9 protein activity Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers 2024-04-02
11925637 Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use Thomas E. Barta, Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Simeon Bowers 2024-03-12
11925606 Compositions for managing chronic obstructive pulmonary disease Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani 2024-03-12
11891369 Compounds for binding proprotein convertase subtilisin/kexin type 9 Simeon Bowers, Thomas E. Barta, Jonathan William Bourne 2024-02-06